Stubbs J T
Bone Research Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892, USA.
Connect Tissue Res. 1996;35(1-4):393-9. doi: 10.3109/03008209609029217.
Bone sialoprotein (BSP) and osteopontin (OPN) are two extracellular bone matrix proteins that have the ability to modulate the growth of hydroxyapatite in vitro. Studies of BSP/OPN hydroxyapatite interactions in the past have been directed toward the identification of essential structural elements that allow these two proteins to modulate hydroxyapatite growth. However, these studies are limited by the finite quantities of purified extracellular matrix proteins. I have utilized a recombinant E. coli expression system to obtain milligram quantities of human bone sialoprotein and human osteopontin that may be used to study extracellular matrix protein interactions with hydroxyapatite.
骨唾液蛋白(BSP)和骨桥蛋白(OPN)是两种细胞外骨基质蛋白,它们在体外具有调节羟基磷灰石生长的能力。过去对BSP/OPN与羟基磷灰石相互作用的研究旨在鉴定使这两种蛋白质能够调节羟基磷灰石生长的必需结构元件。然而,这些研究受到纯化的细胞外基质蛋白数量有限的限制。我利用重组大肠杆菌表达系统获得了毫克量的人骨唾液蛋白和人骨桥蛋白,可用于研究细胞外基质蛋白与羟基磷灰石的相互作用。